Interaction of 5-[4′-(N-Methyl-1,3-benzimidazol-2-yl)phenyl]-10,15,20-tri-(N-methyl-3′-pyridyl)porphyrin Triiodide with SARS-CoV-2 Spike Protein
Open Access
- 20 June 2022
- journal article
- research article
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 92 (6) , 1005-1010
Abstract
The results of experimental studies of the interaction of the S-protein with a monohetaryl-substituted porphyrin containing a benzimidazole residue are presented. It has been revealed that the S-protein forms high-affinity complexes with the specified porphyrin. The porphyrin binding by the SARS-CoV-2 S-protein has proceeded stepwise; at the first stage, the driving force of the complexation is electrostatic interaction between the surface negatively charged regions of the protein and cationic substituents of the porphyrin. At the second stage, the target complex of the S-protein with the porphyrin is formed. It has been established that the introduction of 5-[4′-( N -methyl-1,3-benzimidazol-2-yl)phenyl]-10,15,20-tri-( N -methyl-3′-pyridyl)porphyrin triiodide into a solution of the S-protein complex with the angiotensin-converting enzyme leads to the replacement of the latter with the porphyrin. Displacement of the angiotensin-converting enzyme from the complex with the S-protein under the action of 5-[4′-( N -methyl-1,3-benzimidazol-2-yl)phenyl]-10,15,20-tri-( N -methyl-3′-pyridyl)porphyrin triiodide is the experimental evidence for the porphyrin binding at the receptor-binding domain of the S-protein.Keywords
This publication has 17 references indexed in Scilit:
- Molecular Architecture of the SARS-CoV-2 VirusCell, 2020
- A thermostable, closed SARS-CoV-2 spike protein trimerNature Structural & Molecular Biology, 2020
- TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cellsLife Science Alliance, 2020
- Numerical evaluation of spray position for improved nasal drug deliveryScientific Reports, 2020
- Cell entry mechanisms of SARS-CoV-2Proceedings of the National Academy of Sciences of the United States of America, 2020
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methodsActa Pharmaceutica Sinica B, 2020
- SARS-CoV-2 and Coronavirus Disease 2019: What We Know So FarPathogens, 2020
- Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2Journal of Medical Virology, 2020
- Re-epithelialization and immune cell behaviour in an ex vivo human skin modelScientific Reports, 2020
- Gold nanoparticle‐adjuvanted S protein induces a strong antigen‐specific IgG response against severe acute respiratory syndrome‐related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungsMicrobiology and Immunology, 2019